Publikationen in Zusammenarbeit mit Forschern von Hospital de Manises (9)

2024

  1. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

2020

  1. Clinical assessment of risk factors for infection in inflammatory bowel disease patients

    International Journal of Colorectal Disease, Vol. 35, Núm. 3, pp. 491-500

  2. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

2018

  1. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

    Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 535-543

2017

  1. Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial

    Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1293-1301

  2. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

    American Journal of Gastroenterology, Vol. 112, Núm. 7, pp. 1135-1143

2016

  1. Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study

    Inflammatory Bowel Diseases, Vol. 22, Núm. 4, pp. 894-901

  2. Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project

    Inflammatory Bowel Diseases, Vol. 22, Núm. 3, pp. 583-589

2015

  1. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 6, pp. 355-363